DK288686D0 - PHARMACEUTICAL PREPARATIONS - Google Patents

PHARMACEUTICAL PREPARATIONS

Info

Publication number
DK288686D0
DK288686D0 DK288686A DK288686A DK288686D0 DK 288686 D0 DK288686 D0 DK 288686D0 DK 288686 A DK288686 A DK 288686A DK 288686 A DK288686 A DK 288686A DK 288686 D0 DK288686 D0 DK 288686D0
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparations
preparations
pharmaceutical
Prior art date
Application number
DK288686A
Other languages
Danish (da)
Other versions
DK288686A (en
DK167531B1 (en
Inventor
Walter Klose
Gerald Kirsch
Andreas Huth
Wolfgang Froehlich
Henry Laurent
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK288686D0 publication Critical patent/DK288686D0/en
Publication of DK288686A publication Critical patent/DK288686A/en
Application granted granted Critical
Publication of DK167531B1 publication Critical patent/DK167531B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/4211,3-Oxazoles, e.g. pemoline, trimethadione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/422Oxazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/24Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02BINTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B1/00Engines characterised by fuel-air mixture compression
    • F02B1/02Engines characterised by fuel-air mixture compression with positive ignition
    • F02B1/04Engines characterised by fuel-air mixture compression with positive ignition with fuel-air mixture admission into cylinder
DK288686A 1984-10-19 1986-06-19 Pyrrolidinone and oxazolidinone derivatives, and their use for producing pharmaceutical preparations DK167531B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3438839 1984-10-19
DE19843438839 DE3438839A1 (en) 1984-10-19 1984-10-19 PHARMACEUTICAL PREPARATIONS
DE8500472 1985-10-18
PCT/DE1985/000472 WO1986002268A1 (en) 1984-10-19 1985-10-18 Pharmaceutical preparations

Publications (3)

Publication Number Publication Date
DK288686D0 true DK288686D0 (en) 1986-06-19
DK288686A DK288686A (en) 1986-06-19
DK167531B1 DK167531B1 (en) 1993-11-15

Family

ID=6248597

Family Applications (1)

Application Number Title Priority Date Filing Date
DK288686A DK167531B1 (en) 1984-10-19 1986-06-19 Pyrrolidinone and oxazolidinone derivatives, and their use for producing pharmaceutical preparations

Country Status (8)

Country Link
EP (1) EP0198919B1 (en)
JP (2) JPH0742229B2 (en)
AU (2) AU5095885A (en)
DE (2) DE3438839A1 (en)
DK (1) DK167531B1 (en)
FI (1) FI862590A0 (en)
NO (1) NO164897C (en)
WO (1) WO1986002268A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783591A (en) * 1984-10-19 1998-07-21 Schering Aktiengesellschaft Administration of oxazolidinone and pyrolidinone compounds for the treatment of inflammation
US4681940A (en) * 1985-11-19 1987-07-21 American Home Products Corporation 5-[3-[[2-quinolyl]methoxy]phenyl]-1,3-oxazoles
DE3639225A1 (en) * 1986-11-14 1988-05-19 Schering Ag USE OF 5- (SUBST. PHENYL) -OXAZOLIDINONE DERIATES AS PSYCHOPHARMAKA
HU203330B (en) * 1987-06-10 1991-07-29 Pfizer Process for producing oxazolidin-2-one derivatives and hypoglychemic pharmaceutical compositions containing them
ATE106243T1 (en) * 1988-03-24 1994-06-15 Sankyo Co USE OF ISOXAZOLINONES AS CEREBRO-ACTIVE MEDICATIONS.
WO1992002220A1 (en) * 1990-08-03 1992-02-20 Smithkline Beecham Corporation Tnf inhibitors
US5124455A (en) * 1990-08-08 1992-06-23 American Home Products Corporation Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents
US5547979A (en) * 1992-03-30 1996-08-20 Smithkline Beecham TNF inhibition
HUP9702408A3 (en) * 1995-02-10 2000-08-28 Schering Ag Use of 5-phenyloxazolidin-2-one derivatives for the preparation of pharmaceutical compositions treating diseases requiring tumour necrosis factor (tnf) inhibition
DE19540475A1 (en) * 1995-10-20 1997-04-24 Schering Ag Chiral methylphenyloxazolidinones
US6770658B2 (en) * 1998-09-09 2004-08-03 Inflazyme Pharmaceuticals Ltd. Substituted γ-phenyl-Δ-lactams and uses related thereto
RU2340600C2 (en) * 2001-10-16 2008-12-10 Мемори Фармасьютиклз Корпорейшн Derivatives of 4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone as pde-4 inhibitors for treatment of neurological syndromes
WO2004098592A1 (en) * 2003-05-06 2004-11-18 Senju Pharmaceutical Co. Ltd. Composition containing oxazolidinone derivative
AR057218A1 (en) 2005-12-15 2007-11-21 Astra Ab OXAZOLIDINONE COMPOUNDS AND THEIR USE AS PONTENCIATORS OF THE METABOTROPIC GLUTAMATE RECEIVER

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2413935A1 (en) * 1974-03-20 1975-10-16 Schering Ag 4- (POLYALCOXY-PHENYL) -2-PYRROLIDONE
SU888821A3 (en) * 1976-12-03 1981-12-07 Шеринг Аг (Инофирма) Method of preparing 5-(substituted phehyl)-oxazolidinones or their sulphur-containing analogs
DE2655369A1 (en) * 1976-12-03 1978-06-08 Schering Ag 5- (SUBST. PHENYL) -OXAZOLIDINONE AND THEIR SULFUR ANALOGS AND PROCESS FOR THEIR PRODUCTION

Also Published As

Publication number Publication date
FI862590A (en) 1986-06-17
FI862590A0 (en) 1986-06-17
JPH0742229B2 (en) 1995-05-10
EP0198919B1 (en) 1990-02-28
JPH0761978A (en) 1995-03-07
NO862439D0 (en) 1986-06-18
AU5095885A (en) 1986-05-02
WO1986002268A1 (en) 1986-04-24
JPS62501289A (en) 1987-05-21
EP0198919A1 (en) 1986-10-29
DK288686A (en) 1986-06-19
NO164897C (en) 1990-11-28
DE3438839A1 (en) 1986-04-24
NO164897B (en) 1990-08-20
AU4765390A (en) 1990-05-03
NO862439L (en) 1986-06-18
DK167531B1 (en) 1993-11-15
JP2669494B2 (en) 1997-10-27
DE3576118D1 (en) 1990-04-05

Similar Documents

Publication Publication Date Title
DK546886D0 (en) PHARMACEUTICAL PREPARATION
DK481585A (en) PHARMACEUTICAL PREPARATION CONTAINING ANTHRACYCLING LYCOSIDES
DK175685A (en) ANIMAL PHARMACEUTICAL PREPARATIONS
DK413987D0 (en) PHARMACEUTICAL PREPARATIONS
DK259186A (en) NATIONAL PHARMACEUTICAL PREPARATIONS
DK384985D0 (en) ANTIHISTAMINE PREPARATIONS
DK288686D0 (en) PHARMACEUTICAL PREPARATIONS
DK652787A (en) PHARMACEUTICAL PREPARATIONS
DK133786D0 (en) PREPARATIONS
DK111686A (en) SUSTAINABLE PHARMACEUTICAL PREPARATIONS
DK24986D0 (en) PREPARATIONS
DK52086A (en) PHARMACEUTICAL PREPARATIONS CONTAINING ERGOTAL KALOIDS
DK201785A (en) TOPICAL PHARMACEUTICAL PREPARATION
DK447887A (en) PHARMACEUTICAL PREPARATIONS
DK370085A (en) ANTIANAPHYLACTIC ACTIVE PHARMACEUTICAL PREPARATIONS
DK314283A (en) PHARMACEUTICAL PREPARATIONS
DK440188A (en) ANTIEMETICALLY EFFECTIVE PREPARATIONS
DK86785A (en) BROMCRYPTIN PREPARATIONS
DK503386D0 (en) PEPTIME PREPARATIONS
DK466086D0 (en) EXOGENTIC ACIDED ANTACIDIUM PREPARATIONS
DK151785A (en) 3-AMINOALKYLTHIO-1-PHENYLINDOL COMPOUNDS AND PHARMACEUTICAL PREPARATIONS
DK149588D0 (en) XYLOMETAZOLE-CONTAINING PHARMACEUTICAL PREPARATIONS
SE8504793D0 (en) PHARMACEUTICAL PREPARATIONS
SE8404468D0 (en) PHARMACEUTICAL PREPARATION
FR2587217B1 (en) IMMUNOMODULANT PHARMACEUTICAL PREPARATIONS

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired